Advisory Committee

Craig Emmitt Cole, M.D., is a Hematologist at the Karmanos Cancer Institute of McLaren Greater Lansing, and Assistant Professor in the Division of Hematology and Oncology at Michigan State University. 

Dr. Cole’s research interests include multiple myeloma, non-Hodgkin’s lymphoma, therapeutic apheresis, and myelodysplasia. He has published and presented his research at the American Society of Hematology and the American Society for Apheresis national meetings. He also has a commitment to patient empowerment and education working with several local and national patient advocacy associations. 

Dr. Cole received his Bachelor of Science degree in physiology at Michigan State University and the College of Lyman Briggs, in East Lansing Michigan. Dr. Cole went on to receive his doctoral degree at the Ohio State University College of Medicine in Columbus, Ohio. He completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan Health System, Ann Arbor, Michigan. Dr. Cole subsequently had a post-fellowship laboratory research position at the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute in Boston, Massachusetts.

Kirollos Hanna, PharmD, BCPS, BCOP, is the Director of Pharmacy at Minnesota Oncology and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine. Dr. Hanna also serves as an Associate Editor for the Journal of the Advanced Practitioner in Oncology (JADPRO).

Dr. Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, AJHP, Drugs, JOPP, AJMC and JHOP.

Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke's Mountain States Tumor Institute, Boise, ID.

David H. Vesole, MD, PhD, FACP, is Co-Director, Myeloma Division and Director, Myeloma research at the John Theurer Cancer Center at Hackensack Meridian School of Medicine. He is a Professor of Medicine at Georgetown University where he is also Director of the Myeloma Program.

His research interests address all aspects of the management of plasma cell dyscrasias (multiple myeloma, monoclonal gammopathy of undetermined significance, amyloidosis, and Waldenstrom’s macroglolinemia). Dr. Vesole has more than 25 years of clinical research experience in plasma cell dyscrasias and stem cell transplantation and has produced over 250 peer-reviewed publications in these areas.

Dr. Vesole completed a medical degree at Northwestern University and a doctorate in immunology and microbiology at the Medical University of South Carolina. His postdoctoral training included a residency in internal medicine and a fellowship in Hematology and Oncology at University of Iowa Hospitals and Clinics. He earned his Bachelor of Science degree at the University of Iowa.